Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Verrica Pharmaceuticals Inc. (VRCA) had Receiveable Turnover of 1.16 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$5.12M |
|
$-67.00M |
|
$0.75M |
|
$4.38M |
|
$70.88M |
|
$-65.76M |
|
$-1.24M |
|
$-67.00M |
|
$-67.00M |
|
$-67.00M |
|
$-67.00M |
|
$-67.00M |
|
$-67.00M |
|
$-65.76M |
|
$-64.92M |
|
45.34M |
|
45.34M |
|
$-1.48 |
|
$-1.48 |
|
| Balance Sheet Financials | |
$77.53M |
|
$1.05M |
|
$4.07M |
|
$81.60M |
|
$17.02M |
|
$43.90M |
|
$44.81M |
|
$61.83M |
|
$19.76M |
|
$19.76M |
|
$19.76M |
|
42.41M |
|
| Cash Flow Statement Financials | |
$-38.58M |
|
$-0.36M |
|
$74.21M |
|
$34.27M |
|
$69.55M |
|
$35.27M |
|
$14.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.55 |
|
-- |
|
-- |
|
0.69 |
|
2.24 |
|
85.44% |
|
-1283.35% |
|
-1283.35% |
|
-1267.04% |
|
-1307.47% |
|
-1307.47% |
|
$-38.94M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.73 |
|
|
Receiveable Turnover |
1.16 |
314.57 |
|
-338.99% |
|
-338.99% |
|
-82.10% |
|
-105.23% |
|
$0.47 |
|
$-0.86 |
|
$-0.85 |
|